Bigfoot Biomedical Archives - Medical Design Sourcing

The biggest stories from the American Diabetes Association (ADA) 2023 Scientific Sessions

From left: the Insulet Omnipod 5, Medtronic MiniMed 780G and the Senseonics Eversense E3. These technologies were part of some of the biggest stories from the American Diabetes Associations’ 2023 Scientific Sessions. [Images courtesy of Insulet, Medtronic and Senseonics]

As it does every year, this past week, the American Diabetes Association convened its Scientific Sessions to bring together leaders in the diabetes space.

At last year’s event, next-generation technologies from the big hitters took the spotlight. The 83rd iteration this past week produced a range of new studies, product updates and positive news for a number of technologies and innovations. From continuous glucose monitors (CGMs) to insulin pumps to digital platforms and diabetes reversal procedures, ADA 2023 saw it all.

Usual suspects, like Dexcom, Abbott, Medtronic and Insulet shared their updates. Meanwhile, promising data came …

Diabetes tech is off to a hot start in 2022

Diabetes technology developers have high hopes for the year ahead, some of which have already come to fruition.

Change is continuous in continuous glucose monitoring (GCM), with expanded wear-times, improved accuracy and more. Meanwhile, never-ending innovation in insulin delivery is delivering wearable patches and closedloop delivery systems, making insulin management easier for people with diabetes.

Expectations were already high for new technology coming out of the diabetes space, and significant improvements last year only lifted those hopes higher. Let’s check in with a few companies promising big steps forward, including some that have already made significant progress.

Get the full story at our sister site, Drug Delivery Business News.

How Bigfoot Biomedical plans to take diabetes management forward

Bigfoot Biomedical’s smart insulin pen cap [Image from Bigfoot Biomedical]

For close to 20 years, Jeffrey Brewer has focused on finding ways to support insulin delivery and manage diabetes.

Mazlish was the first person in the world to hack into an insulin pump and continuous glucose monitor (CGM) and enable a do-it-yourself closed-loop insulin dosing system, Brewer told Drug Delivery Business News.

“It turned my attention to the opportunities as an entrepreneur that I might be able to pursue, and then doing so with him, to see what we could add to the equation in terms of industry and how you can take technologies and make them usable and easy and ultimately make life more convenient, easy and safe for people with insulin-requiring diabetes,” said Brewer, who is CEO of Bigfoot. “We’ve been on this journey for about seven years now.”

Initially an entrepreneur, Brewer got involved with the Juvenile …

Bigfoot Biomedical raises $55m in Series C

Diabetes treatment tech company Bigfoot Biomedical announced today that it raised $55 million to close its Series C financing round.

Abbott (NYSE:ABT) led the funding round with participation from new investor Smile Group and existing investors Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management.

Get the full story at our sister site, MassDevice.